A. I. Tarasenko

A. I. Tarasenko

Auto-generated profile, based on publicly available information

A. I. Tarasenko

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2021 in National Health Care (Russia)
Verified
Journal Article
Open access
PDF file
IKI. N. Kagramanyan
I. N. Kagramanyan
ATA. I. Tarasenko
A. I. Tarasenko
IKI. A. Kupeeva
I. A. Kupeeva
OYO. O. Yanushevich
O. O. Yanushevich
KPK. A. Pashkov
K. A. Pashkov
АЕА. О. Ефимова
А. О. Ефимова
The history of medical and pharmaceutical education development is part of the social history. The quality of medical personnel training determines the efficiency of the entire health care system and has been a priority area of development throughout the history of the Russian state. The paper reflects the main stages of the medical education system development in the period from the 17th century to the present. The training of medical personnel in Russia began in the second half of the 17th century, when, under the Pharmaceutical Order, a medical school was established in 1654to train doctors for the needs of the army.The need to provide qualified medical personnel remains relevant, both in wartime and in peacetime. The reforms of medical education that have been taking place over the centuries make it possible to diversify educational programs, as well as the to introduce new educational technologies, considering modern requirements and global trends. The study of the historical aspects of domestic medicine determines a more competent approach to the development of the health care system and medical education.

5 October 2021 in Urology Herald
Verified
Journal Article
Open access
PDF file
AKA. I. Khotko
A. I. Khotko
DKD. N. Khotko
D. N. Khotko
VPV. M. Popkov
V. M. Popkov
АТА. И. Тарасенко
А. И. Тарасенко
Introduction. Timely unresolved upper urinary tract (UUT) obstruction in patients with infection can cause severe complications, such as sepsis, pyonephrosis and even death. There are no clear recommendations regarding the methods and timing of drainage. At the same time, this issue is still the subject of discussion in publications of recent years.Purpose of the study. To optimize the timing of lithotripsy after drainage of the UUT in patients with urolithiasis and obstructive uropathy (OU).Materials and methods. At the first stage, 90 patients with OU caused by the stone of the ureteropelvic junction underwent drainage of the UUT using a percutaneous nephrostomy. Subsequently, percutaneous nephrolithotripsy (PNLT) was performed at various times after drainage. The level of inflammatory markers (IL-8) and profibrotic factor (MCP-1) in the urine was determined. The calculated concentrations of urinary biomarkers were normalized by the level of urinary creatinine. Urine sampling for the analysis was carried out during and after the PCN placement (nephrostomy urine) 7 days later, and then once weekly before surgery. The coefficient K was calculated using a patented formula to evaluate the process of kidney remodeling. Urine sampling was performed for culture to determine the bacterial spectrum and antibiotic sensitivity.Results. The values of K ≤ 1.85 were observed in 11 patients of the group with OU (12.2%), K > 1.85 in 79 (87.8%) by day 21. The values of K ≤ 1.85 were achieved in 70 patients (88.6%) by day 28 and 4 patients (80.0%) by day 35. PNLT was performed on 21 days in patients with K ≤ 1.85 (11 patients), no complications were noted in the postoperative period., PNLT was performed in patients with K ≤ 1.85 (70 patients) by day 28, exacerbation of pyelonephritis and the development of chronic kidney disease were not noted. Six patients with values of K ˃ 1.85 underwent PNLT by day 28. In the postoperative period, all patients had an exacerbation of calculous pyelonephritis, 50% had a decrease in glomerular filtration rate within 3 months after surgery. The bacteria in urine were detected in 55 (61.0%) patients. Escherichia coli (63.0%), Proteus mirabilis (18.0%), Enterococcus faecalis (14.5%), Streptococcus haemolyticus (2.5%) were identified most often.Conclusion. The use of the developed remodeling index allows optimizing the surgery timing and minimizing the development of complications during the postoperative period. The presence of bacteria is associated with a long process of renal parenchymal remodeling.

7 January 2025 in Urology Herald
Verified
Journal Article
Open access
PDF file
DKD. N. Khotko
D. N. Khotko
AKA. I. Khotko
A. I. Khotko
ATA. I. Tarasenko
A. I. Tarasenko
VPV. M. Popkov
V. M. Popkov
   Introduction. Percutaneous nephrolithotripsy is an important minimally invasive method for treating kidney stones. It is appreciated for its low injury rate and quick recovery. However, one of the most serious complications that can occur after this procedure is calculous pyelonephritis. The timing and safe removal of nephrostomy drainage in the postoperative period remain a significant concern for urologists.   Objective. To determine the possibility of using joulemetry and monitoring urinary IL-8 levels to diagnose stone-related pyelonephritis activity following percutaneous nephrolithotripsy.   Materials & methods. The study involved 220 patients with kidney stones who had percutaneous nephrolithotripsy at the SSMU Urology Clinic in 2022 – 2023. The patients were aged between 25 and 65 years, including 135 women (61.3 %) and 85 men (38.7 %). The control group consisted of 30 healthy people aged 24 to 67 years: 18 women (60 %) and 12 men (40 %). After surgery, electrochemical urine examination using the joulemetric method according to a patented technique was performed for patients with stone-related pyelonephritis and for those in the control group.   Results. When analysing the urine IL-8 level, leukocyturia in the urine test, and the current operation based on joulemetry data, we observe a significant increase in all studied parameters on day 1 compared to the control group (p > 0.05). The values of the studied indicators reach their peak range by day 3 and return to those of the control group by day 5. At the same time, even if there is no leukocyturia on day three, the values of the current parameter and the urine IL-8 level remain elevated in most patients.   Conclusion. Joulemetry helps to diagnose the activity of stone-related pyelonephritis in the postoperative period. This is confirmed by general clinical examinations and the determination of urine IL-8 as a marker of inflammation. Using this method allows optimising the timing of drainage removal after surgery.

23 June 2021 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
ATA. I. Tarasenko
A. I. Tarasenko
VPValentin Nikolaevich Pavlov
Valentin Nikolaevich Pavlov
IKI. R. Kabirov
I. R. Kabirov
AAA. V. Alekseev
A. V. Alekseev
MUM. F. Urmantsev
M. F. Urmantsev
Purpose of the study. To assess the clinical and prognostic significance of serum and urinary cystatin C (uCys-C and sCys-C) in patients undergoing radical cystectomy (RC) in relation to AKI.Patients and methods. In this prospective study, uCys-C and sCys-C levels were measured during the first week after undergoing RC in a heterogeneous group of patients undergoing RC (n=186), mean age 59.5±11.4 years. The observation period of the patients was 6 months. The diagnosis of AKI that developed within the first week after surgery was based on the KDIGO criteria.Results. Of the 186 examined patients, 43 developed AKI according to generally accepted criteria. During the follow-up period, no patient required renal replacement therapy. AKI patients had a longer hospital stay (22.4±22.9 versus 13.0±4.1). The sCys-C levels were significantly associated with the occurrence of AKI and CKD in the long-term postoperative period and had an area under the ROC curve of 0.76 and 0.81, respectively, for predicting severe outcomes. At an optimal cut-off value of 161.17 ng/ml, sCys-C showed a sensitivity of 65 % and a specificity of 58 % for predicting AKI. The greatest increase in the concentration of sCys-C was detected 6-12 hours after surgery, followed by a decrease in the long-term follow-up.Conclusion. Peak sCys-C levels are associated with AKI and independently predict the development of AKI in patients after RC and the onset of CKD within 6 months.

4 May 2022 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
ATA. I. Tarasenko
A. I. Tarasenko
ARA. N. Rossolovskiy
A. N. Rossolovskiy
OBO. L. Berezinets
O. L. Berezinets
Alla BucharskayaAlla Bucharskaya
Alla Bucharskaya
SPS. S. Pakhomiy
S. S. Pakhomiy
Galina MaslyakovaGalina Maslyakova
Galina Maslyakova
Purpose of the study. The study's objective is to investigate the expression level of tissue and serum markers of oncogenesis and nephrofibrosis transforming growth factor beta (TGF‑β) and matrix metalloproteinase‑9 (MMP‑9) in patients operated for various stages of renal cell carcinoma.Materials and methods. The study prospectively included medical data of 60 patients with kidney cancer with T1–3N0M0 who received surgical treatment in the Clinic of Urologynamed after S. R. Mirotvortsev of the State Medical University from 2016 to 2019. The patients were divided into 3 groups: Group 1 included 20 patients who underwent laparoscopic kidney resection; Group 2–20 patients who underwent laparoscopic nephrectomy; Group 3–20 patients who underwent open nephrectomy. The control group consisted of 15 healthy volunteers without chronic kidney diseases. All patients signed an informed consent to participate in the study. All patients at the preoperative stage, in the early (7–10 days) and remote postoperative periods (after 1 and 2 years) were tested by solid‑phase ELISA on a StatFax 4200 analyzer using eBiosence and Cloud‑Clone Corp reagent kits for the serum concentration of oncogenesis markers MMP‑9 and TGF‑β1.Results. Initial increase of MMP‑9 concentration was detected in all groups of PCC patients compared to the control group (p ≤ 0.05). According to the results of ROC analysis, this indicator has high specificity and sensitivity for prognosis of preoperative stage of renal cell carcinoma. The sensitivity and specificity of MMP‑9 were 87.5 % and 62 %, respectively, and the diagnostically significant level of MMP‑9 was 958 ng/ml. A comprehensive analysis of the content of MMP‑9 and TGF‑β1 oncogenesis markers in serum and tumor cells revealed the correlation of these indicators in various biological objects.Conclusion. Markers of oncogenesis and nephrofibrosis TGF‑β1 and MMP‑9 provide an opportunity for non‑invasive monitoring of tumor progression and probability of metastasis in the clinical setting. Serum MMP‑9 are a reliable predictor of tumor growth. Serum TGF‑β1 concentration isn't a sufficiently reliable marker of tumor progression.

25 December 2024 in Experimental and Сlinical Urology
Verified
Journal Article
Closed access
NPN.V. Polukonova
N.V. Polukonova
RSRussia Saratov
Russia Saratov
DKD.N. Khotko
D.N. Khotko
Alla BucharskayaAlla Bucharskaya
Alla Bucharskaya
AKA.I. Khotko
A.I. Khotko
RSRussia The State Medical Institution «Sgkb No.8»; Saratov
Russia The State Medical Institution «Sgkb No.8»; Saratov
Introduction. Urolithiasis is a multifactorial disease affecting all population groups. The incidence of urolithiasis in different countries varies from 1,7 to 14,8%. The risk of developing urolithiasis depends on age, gender, race, geographic location and hereditary predisposition, while 40-50% of patients have a burdened family history, so the search for genetic markers associated with urolithiasis is relevant. Materials and methods. The search results were analyzed regardless of the date and language of publication in the scientific databases eLibrary, PubMed for the following keywords: urolithiasis, single nucleotide polymorphisms (SNP), calcium oxalate, cystine, urate stones. After analyzing the literature, 49 works were selected for review that most fully reflect the topic of key genes and polymorphism in urolithiasis associated with the formation of calcium oxalate, cystine and urate stones. Results. The analysis has shown that the role of genetic factors in the formation of concrements of different composition is not equal. Oxalate calcium urolithiasis is a multifactorial disease associated with hypercalciuria, its determinant genes and SNPs: CALCR (rs1801197: «1377C>T»; «1340T>C» and «A>G»; rs1042138 (C>T), CaSR (rs6776158A>G of promoter 1), Klotho (rs1207568A>G; rs3752472T> C and rs650439), OPN (SPP1 rs2853744G>T) and VDR (ApaI (rs7975232) and TaqI (rs731236). SNPs in calcium oxalate urolithiasis are more often inherited by autosomal recessive type and localized in the coding or promoter regions of the gene, and the manifestation of the disease depends on ethnicity. Cystinuria is an inherited disease for which SNPs of two genes are re- sponsible: SLC3A1 with autosomal recessive inheritance (cystinuria type A, or type I) and SLC7A9 with incomplete recessive inheritance (cystinuria type B, or «not type I», types II and III). The genetic heterogeneity of cystinuria by SNP varies in different populations depending on the degree of its panmixis. The presence of type AB (SNPs in both genes) in patients suggests that cystinuria may be a digenetic disease. And the absence of mutations in patients with cystonuria indicates the involvement of not yet identified genes. Formation of hyperuricemia is a multifactorial disease, both with the participation of many rare and low-frequency SNPs of the gene SLC22A12, and with recessive inheritance of widespread SNP genes: SLC2A9, ABCG2. Conclusions. The obtained data allow a personalized approach to treatment and prevention of oxalate, cystine and urate concretions in urolithiasis.